Kornitzer Capital Management’s Intersect ENT, Inc XENT Stock Holding History

Kornitzer Capital Management’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-57,500	Closed	-$986K	–	487
2017 Q1	$986K	Sell	57,500 -35,900	-38%	-$503K	0.02%	375
2016 Q4	$1.13M	Sell	93,400 -30,200	-24%	-$391K	0.02%	363
2016 Q3	$1.96M	Sell	123,600 -45,500	-27%	-$685K	0.04%	304
2016 Q2	$2.19M	Buy	169,100 +41,700	+33%	+$653K	0.04%	299
2016 Q1	$2.42M	Buy	127,400 +43,700	+52%	+$792K	0.04%	289
2015 Q4	$1.88M	Buy	83,700 +4,400	+6%	+$87K	0.03%	316
2015 Q3	$1.86M	Sell	79,300 -80,000	-50%	-$2.21M	0.03%	322
2015 Q2	$4.56M	Sell	159,300 -6,000	-4%	-$157K	0.06%	272
2015 Q1	$4.27M	Buy	165,300 +28,300	+21%	+$647K	0.05%	271
2014 Q4	$2.54M	Sell	137,000 -3,000	-2%	-$54K	0.03%	304
2014 Q3	$2.17M	Buy	+140,000	New	+$2.11M	0.02%	303

Other funds holding XENT

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Kornitzer Capital Management's XENT Position: Q2 2017 in Review

Kornitzer Capital Management sold out of Intersect ENT, Inc (XENT) in Q2 2017, closing a stake of 57,500 shares — an estimated $986K sold.

Kornitzer Capital Management first reported a position in XENT in Q3 2014 and held it in 11 quarters. The position peaked at $4.56M in Q2 2015. 128 funds tracked by Wall St. Rank hold XENT as of Q2 2017.

Kornitzer Capital Management reported no remaining Intersect ENT, Inc position as of Q2 2017 after selling out during the quarter.
Kornitzer Capital Management sold 57,500 Intersect ENT, Inc shares in Q2 2017, an estimated $986K.
Kornitzer Capital Management first reported a position in Intersect ENT, Inc in Q3 2014 and held it in 11 quarters.
Kornitzer Capital Management's Intersect ENT, Inc position peaked at $4.56M in Q2 2015.
128 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2017.

Based on Kornitzer Capital Management's 13F filing for Q2 2017, filed 27 Jul 2017.